-
Ammatuna P, Campisi G, Giovannelli L, Giambelluca D, Alaimo C, Mancuso S, Margiotta V, 2001: Presence of Epstein-Barr virus, cytomegalovirus and human papillomavirus in normal oral mucosa of HIV-infected and renal transplant patients[J]. Oral Dis, 7, 34-40.
-
Amornthatree K, Sriplung H, Mitarnun W, Nittayananta W, 2012: Effects of long-term use of antiretroviral therapy on the prevalence of oral Epstein-Barr virus[J]. J Oral Pathol Med, 41, 249-254. doi: 10.1111/jop.2012.41.issue-3
-
Balfour HH Jr, Odumade OA, Schmeling DO, Mullan BD, Ed JA, Knight JA, Vezina HE, Thomas W, Hogquist KA, 2013: Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students[J]. J Infect Dis, 207, 80-88. doi: 10.1093/infdis/jis646
-
Burnham KE, Cruess DG, Kalichman MO, Grebler T, Cherry C, Kalichman SC, 2016: Trauma symptoms, internalized stigma, social support, and sexual risk behavior among HIV-positive gay and bisexual MSM who have sought sex partners online[J]. AIDS Care, 28, 347-353. doi: 10.1080/09540121.2015.1096894
-
Cao P, Zhang M, Wang W, Dai Y, Sai B, Sun J, Wang L, Wang F, Li G, Xiang J, 2017: Fluorescence in situ hybridization is superior for monitoring Epstein Barr viral load in infectious mononucleosis patients[J]. BMC Infect Dis, 17, 323-. doi: 10.1186/s12879-017-2412-y
-
Chakraborty N, Bhattacharyya S, De C, Mukherjee A, Bhattacharya D, Santra S, Sarkar RN, Banerjee D, Guha SK, Datta UK, Chakrabarti S, 2010: Incidence of multiple herpesvirus infection in HIV seropositive patients, a big concern for Eastern Indian scenario[J]. Virol J, 7, 147-. doi: 10.1186/1743-422X-7-147
-
Choi SK, Graber CJ, 2014: Acute human immunodeficiency virus (HIV) syndrome after nonadherence to antiretroviral therapy in a patient with chronic HIV infection: a case report[J]. Open Forum Infect Dis, 1, ofu112-. doi: 10.1093/ofid/ofu112
-
Cohen JI, Fauci AS, Varmus H, Nabel GJ, 2011: Epstein-Barr virus: an important vaccine target for cancer prevention[J]. Sci Transl Med, 3, 107f-.
-
Dai SY, Liu JJ, Fan YG, Shan GS, Zhang HB, Li MQ, Ye DQ, 2015: Prevalence and factors associated with late HIV diagnosis[J]. J Med Virol, 87, 970-977. doi: 10.1002/jmv.v87.6
-
de Franca TR, de Albuquerque Tavares Carvalho A, Gomes VB, Gueiros LA, Porter SR, Leao JC, 2012: Salivary shedding of Epstein-Barr virus and cytomegalovirus in people infected or not by human immunodeficiency virus 1[J]. Clin Oral Investig, 16, 659-664. doi: 10.1007/s00784-011-0548-5
-
de-The G, Day NE, Geser A, Lavoue MF, Ho JH, Simons MJ, Sohier R, Tukei P, Vonka V, Zavadova H, 1975: Sero-epidemiology of the Epstein-Barr virus: preliminary analysis of an international study—a review[J]. IARC Sci Publ, 11, 3-16.
-
Fourcade G, Germi R, Guerber F, Lupo J, Baccard M, Seigneurin A, Semenova T, Morand P, Epaulard O, 2017: Evolution of EBV seroprevalence and primary infection age in a French hospital and a city laboratory network, 2000-2016[J]. PLoS One, 12, e0175574-. doi: 10.1371/journal.pone.0175574
-
Grimes RM, Hardwicke RL, Grimes DE, DeGarmo DS, 2016: When to consider acute HIV infection in the differential diagnosis[J]. Nurse Pract, 41, 1-5. doi: 10.1097/01.NPR.0000511092.91174.b4
-
Guidry JT, Birdwell CE, Scott RS (2017) Epstein-Barr virus in the pathogenesis of oral cancers. Oral Dis. https://doi.org/10.1111/odi.12656
-
Hanley PJ, Cruz CRY, Savoldo B, Leen AM, Stanojevic M, Khalil M, Decker W, Molldrem JJ, Liu H, Gee AP, Rooney CM, Heslop HE, Dotti G, Brenner MK, Shpall EJ, Bollard CM, 2009: Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes[J]. Blood, 114, 1958-1967. doi: 10.1182/blood-2009-03-213256
-
Kelly, Weiss, Benavente, de Sanjose, Mayaud, ART and HPV Review Group, 2018: Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis[J]. Lancet HIV, 5, e45-e58. doi: 10.1016/S2352-3018(17)30149-2
-
Liu G, Sharma M, Tan N, Barnabas R, 2018: HIV-positive women have higher risk of HPV infection, precancerous lesions, and cervical cancer: a systematic review and meta-analysis[J]. AIDS, 32, 795-808. doi: 10.1097/QAD.0000000000001765
-
Mocroft A, Lundgren JD, Sabin ML, Monforte A, Brockmeyer N, Casabona J, Castagna A, Costagliola D, Dabis F, De Wit S, Fatkenheuer G, Furrer H, Johnson AM, Lazanas MK, Leport C, Moreno S, Obel N, Post FA, Reekie J, Reiss P, Sabin C, Skaletz-Rorowski A, Suarez-Lozano I, Torti C, Warszawski J, Zangerle R, Fabre-Colin C, Kjaer J, Chene G, Grarup J, Kirk O, 2013: Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)[J]. PLoS Med, 10, e1001510-. doi: 10.1371/journal.pmed.1001510
-
Molina Y, Ramirez-Valles J, 2013: HIV/AIDS stigma: measurement and relationships to psycho-behavioral factors in Latino gay/bisexual men and transgender women[J]. AIDS Care, 25, 1559-1568. doi: 10.1080/09540121.2013.793268
-
Moriuchi M, Moriuchi H, 2003: Increased susceptibility to HIV-1 of peripheral blood lymphocytes in acute infection with Epstein-Barr virus[J]. J Med Virol, 71, 343-346. doi: 10.1002/(ISSN)1096-9071
-
Porter DD, Wimberly I, Benyesh-Melnick M, 1969: Prevalence of antibodies to EB virus and other herpesviruses[J]. JAMA, 208, 1675-1679. doi: 10.1001/jama.1969.03160090035008
-
Rao SC, Ashraf I, Mir F, Samiullah S, Ibdah JA, Tahan V, 2017: Dual infection with hepatitis B and Epstein-Barr virus presenting with severe jaundice, coagulopathy, and hepatitis B virus chronicity outcome[J]. Am J Case Rep, 18, 170-172. doi: 10.12659/AJCR.901688
-
Scaggiante R, Andreis S, Basso M, Franchin E, Franzetti M, Del Vecchio C, Torti C, Mengoli C, Cruciani M, Sarmati L, Palu G, Parisi SG, 2016: Epstein-Barr and cytomegalovirus DNA salivary shedding correlate with long-term plasma HIV RNA detection in HIV-infected men who have sex with men[J]. J Med Virol, 88, 1211-1221. doi: 10.1002/jmv.v88.7
-
Shen Y, Lu H, Wang Z, Qi T, Wang J, 2013: Analysis of the immunologic status of a newly diagnosed HIV positive population in China[J]. BMC Infect Dis, 13, 429-. doi: 10.1186/1471-2334-13-429
-
Shin HR, Shin A, Woo H, Fox K, Walsh N, Lo YR, Wiesen E, Varghese C, 2016: Prevention of infection-related cancers in the WHO Western Pacific Region[J]. Jpn J Clin Oncol, 46, 13-22. doi: 10.1093/jjco/hyv092
-
Sun J, Liu L, Shen J, Chen P, Lu H, 2017: Trends in baseline CD4 cell counts and risk factors for late antiretroviral therapy initiation among HIV-positive patients in Shanghai, a retrospective cross-sectional study[J]. BMC Infect Dis, 17, 285-. doi: 10.1186/s12879-017-2398-5
-
Vargas-Meneses MV, Massanella M, Ignacio CC, Gianella S, 2015: Quantification of HIV RNA and human herpesvirus DNA in seminal plasma[J]. Bio Protoc, 5, e1465-.
-
Wang L, Ge L, Wang L, Morano JP, Guo W, Khoshnood K, Qin Q, Ding Z, Sun D, Liu X, Luo H, Tillman J, Cui Y, 2015: Causes of death among AIDS patients after introduction of free combination antiretroviral therapy (cART) in three Chinese provinces, 2010-2011[J]. PLoS ONE, 10, e0139998-. doi: 10.1371/journal.pone.0139998
-
WHO (2014) WHO Guidelines Approved by the Guidelines Review Committee. Guidelines on Post-Exposure Prophylaxis for HIV and the Use of Co-Trimoxazole Prophylaxis for HIV-Related Infections Among Adults, Adolescents and Children: Recommendations for a Public Health Approach: December 2014 supplement to the 2013 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. World Health Organization Copyright (c) World Health Organization 2014, Geneva
-
Wu Z, Zhao Y, Ge X, Mao Y, Tang Z, Shi CX, Chen C, Li Y, Qiu X, Nong G, Huang S, Luo S, Wu S, He W, Zhang M, Shen Z, Jin X, Li J, Brookmeyer R, Detels R, Montaner J, Wang Y, 2015: Simplified HIV testing and treatment in China: analysis of mortality rates before and after a structural intervention[J]. PLoS Med, 12, e1001874-. doi: 10.1371/journal.pmed.1001874
-
Xiong G, Zhang B, M-Y Huang, Zhou H, Chen LZ, Feng QS, Luo X, Lin HJ, Zeng YX, 2014: Epstein-Barr virus (EBV) infection in Chinese children: a retrospective study of age-specific prevalence[J]. PLoS ONE, 9, e99857-. doi: 10.1371/journal.pone.0099857
-
Yao Y, Luo Y, He Y, Zheng Y, Zhang Q, Zhou H, Zeng S, Chen Z, He B, He M, 2013: The effect of a year of highly active antiretroviral therapy on immune reconstruction and cytokines in HIV/AIDS patients[J]. AIDS Res Hum Retrovir, 29, 691-697. doi: 10.1089/aid.2012.0275
-
Zhang F, Dou Z, Ma Y, Zhang Y, Zhao Y, Zhao D, Zhou S, Bulterys M, Zhu H, Chen RY, 2011: Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study[J]. Lancet Infect Dis, 11, 516-524. doi: 10.1016/S1473-3099(11)70097-4